Search Results - "Dong, Weifan"
-
1
Postsynaptic RIM1 modulates synaptic function by facilitating membrane delivery of recycling NMDARs in hippocampal neurons
Published in Nature communications (11-06-2018)“…NMDA receptors (NMDARs) are crucial for excitatory synaptic transmission and synaptic plasticity. The number and subunit composition of synaptic NMDARs are…”
Get full text
Journal Article -
2
A Feedforward Mechanism Mediated by Mechanosensitive Ion Channel PIEZO1 and Tissue Mechanics Promotes Glioma Aggression
Published in Neuron (Cambridge, Mass.) (21-11-2018)“…Alteration of tissue mechanical properties is a physical hallmark of solid tumors including gliomas. How tumor cells sense and regulate tissue mechanics is…”
Get full text
Journal Article -
3
CNSC-28. IDENTIFICATION OF EAG2-KVß2 POTASSIUM CHANNEL COMPLEX IN NEURON-GBM COMMUNICATIONS REVEALS GBM VULNERABILITY TO DESIGNER INTERFERENCE PEPTIDE
Published in Neuro-oncology (Charlottesville, Va.) (14-11-2022)“…Abstract Glioblastomas (GBMs) are the most aggressive brain tumors. GBM cells form extensive tumoral networks to communicate with each other and with…”
Get full text
Journal Article -
4
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma
Published in Nature (London) (01-10-2019)“…© The Author(s), under exclusive licence to Springer Nature Limited 2019 In cancer, recurrent somatic single-nucleotide variants-which are rare in most…”
Get full text
Journal Article -
5
STEM-27. MECHANOSENSITIVE BRAIN TUMOR CELLS CONSTRUCT BLOOD-TUMOR BARRIER TO MASK CHEMOSENSITIVITY
Published in Neuro-oncology (Charlottesville, Va.) (14-11-2022)“…Abstract Two major obstacles in brain cancer treatment are the blood-tumor barrier (BTB) and quiescent tumor cells. Here we show that Sox2+ tumor cells…”
Get full text
Journal Article -
6
Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity
Published in Neuron (Cambridge, Mass.) (04-01-2023)“…Major obstacles in brain cancer treatment include the blood-tumor barrier (BTB), which limits the access of most therapeutic agents, and quiescent tumor cells,…”
Get full text
Journal Article -
7
Pan-cancer ion transport signature reveals functional regulators of glioblastoma aggression
Published in The EMBO journal (16-01-2024)“…Ion channels, transporters, and other ion-flux controlling proteins, collectively comprising the “ion permeome”, are common drug targets, however, their roles…”
Get full text
Journal Article -
8
Chloride intracellular channel 1 cooperates with potassium channel EAG2 to promote medulloblastoma growth
Published in The Journal of experimental medicine (04-05-2020)“…Ion channels represent a large class of drug targets, but their role in brain cancer is underexplored. Here, we identify that chloride intracellular channel 1…”
Get full text
Journal Article -
9
CNSC-20. MONOSYNAPTIC TRACING DEFINES BRAIN-WIDE CIRCUIT CONNECTIVITY OF HUMAN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…Abstract Glioblastoma (GBM), a deadly brain cancer, infiltrates the brain and can be synaptically innervated by neurons. Synaptic inputs onto GBM cells…”
Get full text
Journal Article -
10
Mechanical nanosurgery of chemoresistant glioblastoma using magnetically controlled carbon nanotubes
Published in Science advances (29-03-2023)“…Glioblastoma (GBM) is the most common and aggressive primary brain cancer. Despite multimodal treatment including surgery, radiotherapy, and chemotherapy,…”
Get full text
Journal Article -
11
STEM-26. BLOOD-TUMOR BARRIER IS COMPOSED OF MECHANOSENSING TUMOR CELLS THAT MASK THERAPEUTIC VULNERABILITY
Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)“…Abstract Two major obstacles in brain cancer treatment are the blood-tumor barrier (BTB), which restricts delivery of most therapeutic agents, and the…”
Get full text
Journal Article -
12
A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma
Published in Nature cancer (01-10-2023)“…Glioblastoma (GBM) is an incurable brain cancer that lacks effective therapies. Here we show that EAG2 and Kvβ2, which are predominantly expressed by GBM cells…”
Get full text
Journal Article -
13
Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma
Published in Nature (London) (09-10-2019)“…Recurrent somatic single nucleotide variants (SNVs) in cancer are largely confined to protein-coding genes, and are rare in most paediatric cancers . Here we…”
Get full text
Journal Article -
14
Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma
Published in Nature (London) (01-10-2019)“…Recurrent somatic single nucleotide variants (SNVs) in cancer are largely confined to protein coding genes, and are rare in most pediatric cancers 1 – 3 . We…”
Get full text
Journal Article